Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$0.55 USD
-0.03 (-5.21%)
Updated Aug 8, 2024 03:58 PM ET
After-Market: $0.55 0.00 (0.00%) 6:32 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 41.18% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.37 |
Next Year | -0.35 |
EPS (TTM) | -0.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.10 | -0.37 | -0.35 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.10 | -0.11 | -0.39 | -0.35 |
High Estimate | -0.08 | -0.08 | -0.34 | -0.35 |
Low Estimate | -0.10 | -0.11 | -0.39 | -0.35 |
Year ago EPS | -0.16 | -0.14 | -0.61 | -0.37 |
Year over Year Growth Est. | 43.75% | 28.57% | 39.34% | 4.05% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.10 | -0.37 | -0.35 |
7 Days Ago | -0.09 | -0.10 | -0.37 | -0.35 |
30 Days Ago | -0.09 | -0.10 | -0.37 | -0.35 |
60 Days Ago | -0.09 | -0.10 | -0.37 | -0.35 |
90 Days Ago | -0.11 | -0.11 | -0.47 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.10 | -0.37 | -0.35 |
Zacks Consensus Estimate | -0.09 | -0.10 | -0.37 | -0.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.12 | -0.14 | -0.16 | NA |
Estimate | -0.17 | -0.17 | -0.19 | -0.19 | NA |
Difference | 0.07 | 0.05 | 0.05 | 0.03 | 0.05 |
Surprise | 41.18% | 29.41% | 26.32% | 15.79% | 28.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more